BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21805729)

  • 1. [Specific biomarkers for the diagnosis and prognosis of hepatocellular carcinoma].
    Wang HY
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):241-3. PubMed ID: 21805729
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of histological biopsy diagnosis of hepatocellular carcinoma by genomic biomarkers?
    Lamerz R
    Gut; 2011 Jul; 60(7):881-2. PubMed ID: 21436226
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PIVKA-II high-sensitivity PIVKA-II].
    Fujiyama S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():349-55. PubMed ID: 11761970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].
    Aoyagi Y; Yanagi M; Asakura H
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2003-7. PubMed ID: 8586921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Kubota T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():625-8. PubMed ID: 16149595
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrolamellar carcinoma of the liver: hepatocellular carcinoma with favourable prognosis].
    Denis J; Grippon P; Legendre C; Tubiana JM; Lévy VG
    Gastroenterol Clin Biol; 1984 Dec; 8(12):920-4. PubMed ID: 6097494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma].
    Aoyagi Y; Mita Y; Kuroiwa T; Wakuri N; Kawai H; Kobayashi M; Igarashi M; Suda T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():342-8. PubMed ID: 11761969
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
    Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
    J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extrahepatic intrabile duct tumor growth of hepatocellular carcinoma].
    Kashihara T; Ohki A; Tako H; Kiso S
    Ryoikibetsu Shokogun Shirizu; 1996; (9):57-60. PubMed ID: 8705559
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma presenting with obstructive jaundice: a clinicopathological study of eight cases.
    Murata K; Shiraki K; Kawakita T; Yamamoto N; Okano H; Sakai T; Ohmori S; Deguchi M; Shimizu A; Nakano T
    Hepatogastroenterology; 2003; 50(54):2057-60. PubMed ID: 14696464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological studies in patients with hepatocellular carcinoma. III. Clinical application of prognosis forecasting by computer (author's transl)].
    Nishioka M; Kan D; Nawata J; Takemoto T; Fukuda T; Miyaji T
    Rinsho Byori; 1980 Mar; 28(3):285-7. PubMed ID: 6246291
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liver transplantation for hepatocellular carcinoma].
    Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinicopathological study of juvenile hepatocellular carcinoma with hepatitis B virus infection].
    Kitagawa S; Nakanuma Y; Kaizaki Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():381-6. PubMed ID: 15453351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases].
    Caselmann WH; Blum HE; Fleig WE; Huppert PE; Ramadori G; Schirmacher P; Sauerbruch T
    Z Gastroenterol; 1999 May; 37(5):353-65. PubMed ID: 10413843
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of Nostradamus.
    Trevisani F; Santi V
    Dig Liver Dis; 2009 Jun; 41(6):382-4. PubMed ID: 19328052
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathological diagnosis of hepatocellular carcinoma].
    Nakashima O
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():333-41. PubMed ID: 11761968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.